Effect of Low-Fat Diets on Plasma Levels of NF-κB–Regulated Inflammatory Cytokines and Angiogenic Factors in Men with Prostate Cancer

Diet, nutritional status, and certain dietary supplements are postulated to influence the development and progression of prostate cancer. Angiogenesis and inflammation are central to tumor growth and progression, but the effect of diet on these processes remains uncertain. We explored changes in 50 plasma cytokines and angiogenic factors (CAF) in 145 men with prostate cancer enrolled in a preoperative, randomized controlled phase II trial with four arms: control (usual diet), low-fat (LF) diet, flaxseed-supplemented (FS) diet, and FS+LS diet. The mean duration of dietary intervention was 30 to 31 days. Among the individual arms, the largest number of significant changes (baseline vs. preoperative follow-up) was observed in the LF arm, with 19 CAFs decreasing and one increasing (P < 0.05). Compared with the control arm, 6 CAFs—including proangiogenic factors (stromal-cell derived-1α) and myeloid factors (granulocyte-colony-stimulating factor, macrophage colony-stimulating factor)—all decreased in the LF arm compared with controls; three and four CAFs changed in the FS and FS+LF arms, respectively. Weight loss occurred in the LF arms and significantly correlated with VEGF decreases (P < 0.001). The CAFs that changed in the LF arm are all known to be regulated by NF-κB, and a pathway analysis identified NF-κB as the most likely regulatory network associated with these changes in the LF arm but not in the FS-containing arms. These results suggest that a LF diet without flaxseed may reduce levels of specific inflammatory CAFs and suggests that the NF-κB pathway may be a mediator of these changes. Cancer Prev Res; 4(10); 1590–8. ©2011 AACR.

[1]  T. Guthrie,et al.  Prostate cancer. , 2020, American family physician.

[2]  Priya Bhardwaj,et al.  Obesity Is Associated with Inflammation and Elevated Aromatase Expression in the Mouse Mammary Gland , 2011, Cancer Prevention Research.

[3]  S. Hursting Inflammatory Talk: Linking Obesity, NF-κB, and Aromatase , 2011, Cancer Prevention Research.

[4]  A. Jemal,et al.  Global Patterns of Cancer Incidence and Mortality Rates and Trends , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[5]  Jun Hee Lee,et al.  Dietary and Genetic Obesity Promote Liver Inflammation and Tumorigenesis by Enhancing IL-6 and TNF Expression , 2010, Cell.

[6]  Jeffrey S. Morris,et al.  Phase II trial of infusional fluorouracil, irinotecan, and bevacizumab for metastatic colorectal cancer: efficacy and circulating angiogenic biomarkers associated with therapeutic resistance. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  Edward S. Kim,et al.  Distinct patterns of cytokine and angiogenic factor modulation and markers of benefit for vandetanib and/or chemotherapy in patients with non-small-cell lung cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  E. Cummins,et al.  The Role of NF‐κB in Hypoxia‐Induced Gene Expression , 2009, Annals of the New York Academy of Sciences.

[9]  Chun-Yin Huang,et al.  Stromal cell‐derived factor‐1/CXCR4 enhanced motility of human osteosarcoma cells involves MEK1/2, ERK and NF‐κB‐dependent pathways , 2009, Journal of cellular physiology.

[10]  C. Drevon,et al.  Diet-induced obesity increases NF-κB signaling in reporter mice , 2009, Genes & Nutrition.

[11]  P. Febbo,et al.  The Effects of Varying Dietary Carbohydrate and Fat Content on Survival in a Murine LNCaP Prostate Cancer Xenograft Model , 2009, Cancer Prevention Research.

[12]  F. Balkwill Tumour necrosis factor and cancer , 2009, Nature Reviews Cancer.

[13]  W. Demark-Wahnefried,et al.  Enterolactone inhibits insulin-like growth factor-1 receptor signaling in human prostatic carcinoma PC-3 cells. , 2009, The Journal of nutrition.

[14]  B. Aggarwal,et al.  Targeting Inflammatory Pathways for Prevention and Therapy of Cancer: Short-Term Friend, Long-Term Foe , 2009, Clinical Cancer Research.

[15]  K. Owzar,et al.  Flaxseed Supplementation (Not Dietary Fat Restriction) Reduces Prostate Cancer Proliferation Rates in Men Presurgery , 2008, Cancer Epidemiology Biomarkers & Prevention.

[16]  Haiyan Xu,et al.  Obesity-Related Upregulation of Monocyte Chemotactic Factors in Adipocytes , 2008, Diabetes.

[17]  S. George,et al.  Overcoming challenges in designing and implementing a phase II randomized controlled trial using a presurgical model to test a dietary intervention in prostate cancer , 2008, Clinical trials.

[18]  W. Demark-Wahnefried,et al.  Enterolactone induces apoptosis in human prostate carcinoma LNCaP cells via a mitochondrial-mediated, caspase-dependent pathway , 2007, Molecular Cancer Therapeutics.

[19]  S. Chua,et al.  Obesity, metabolic syndrome, and prostate cancer. , 2007, The American journal of clinical nutrition.

[20]  Robert M Elashoff,et al.  Dietary fat reduction and breast cancer outcome: interim efficacy results from the Women's Intervention Nutrition Study. , 2007, Journal of the National Cancer Institute.

[21]  Wan-Wan Lin,et al.  A cytokine-mediated link between innate immunity, inflammation, and cancer. , 2007, The Journal of clinical investigation.

[22]  Laura Herrero,et al.  Obesity, inflammation, and insulin resistance. , 2007, Gastroenterology.

[23]  B. Aggarwal,et al.  Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-kappaB-regulated gene products. , 2007, Cancer research.

[24]  I. Thompson,et al.  Obesity, Diabetes, and Risk of Prostate Cancer: Results from the Prostate Cancer Prevention Trial , 2006, Cancer Epidemiology Biomarkers & Prevention.

[25]  A. Goldfine,et al.  Inflammation and insulin resistance. , 2006, The Journal of clinical investigation.

[26]  Silvano Sozzani,et al.  The chemokine system in diverse forms of macrophage activation and polarization. , 2004, Trends in immunology.

[27]  D. Bostwick,et al.  Human prostate cancer risk factors , 2004, Cancer.

[28]  A. Aljada,et al.  Circulating Mononuclear Cells in the Obese Are in a Proinflammatory State , 2004, Circulation.

[29]  B. Aggarwal Nuclear factor-κB: The enemy within , 2004 .

[30]  Bharat B. Aggarwal,et al.  Nuclear factor-κB: its role in health and disease , 2004, Journal of Molecular Medicine.

[31]  C. Gutiérrez,et al.  Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: relationships in obesity. , 2004, Obesity research.

[32]  A. Aljada,et al.  Increase in intranuclear nuclear factor κB and decrease in inhibitor κB in mononuclear cells after a mixed meal: evidence for a proinflammatory effect , 2004 .

[33]  M. Terris,et al.  Impact of obesity on biochemical control after radical prostatectomy for clinically localized prostate cancer: a report by the Shared Equal Access Regional Cancer Hospital database study group. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[34]  B. Lowell,et al.  Adipose tissue mass can be regulated through the vasculature , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[35]  W. Willett Dietary fat plays a major role in obesity: no , 2002, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[36]  N. Hacohen,et al.  Tumor necrosis factor-α suppresses adipocyte-specific genes and activates expression of preadipocyte genes in 3T3-L1 adipocytes: Nuclear factor-κB activation by TNF-α is obligatory , 2002 .

[37]  M. Thun,et al.  American Cancer Society Guidelines on Nutrition and Physical Activity for Cancer Prevention: Reducing the Risk of Cancer With Healthy Food Choices and Physical Activity , 2002, CA: a cancer journal for clinicians.

[38]  W. Demark-Wahnefried,et al.  Effect of mammalian lignans on the growth of prostate cancer cell lines. , 2001, Anticancer research.

[39]  W. Aronson,et al.  Evidence of an inhibitory effect of diet and exercise on prostate cancer cell growth. , 2001, The Journal of urology.

[40]  J. Ward,et al.  Eotaxin (CCL11) Induces In Vivo Angiogenic Responses by Human CCR3+ Endothelial Cells1 , 2001, The Journal of Immunology.

[41]  G. Hallmans,et al.  Phytoestrogens and prostate disease. , 2000, The Journal of nutrition.

[42]  D. L. Crandall,et al.  A Review of the Microcirculation of Adipose Tissue: Anatomic, Metabolic, and Angiogenic Perspectives , 1997, Microcirculation.

[43]  T. Rosengart,et al.  Vascular endothelial growth factor is the major angiogenic factor in omentum: mechanism of the omentum-mediated angiogenesis. , 1997, The Journal of surgical research.

[44]  Q. Hamid,et al.  Human monocyte chemoattractant protein (MCP)-4 is a novel CC chemokine with activities on monocytes, eosinophils, and basophils induced in allergic and nonallergic inflammation that signals through the CC chemokine receptors (CCR)-2 and -3. , 1996, Journal of immunology.

[45]  P. Leder,et al.  Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia , 1996, Nature Medicine.

[46]  B. Aggarwal,et al.  Characterization of receptors for human tumour necrosis factor and their regulation by γ-interferon , 1985, Nature.

[47]  W. E. Gye,et al.  CANCER RESEARCH , 1923, British medical journal.

[48]  S. Freedland,et al.  Growth inhibitory effect of low fat diet on prostate cancer cells: results of a prospective, randomized dietary intervention trial in men with prostate cancer. , 2010, The Journal of urology.

[49]  S. Pizzo,et al.  Carbohydrate restriction, prostate cancer growth, and the insulin‐like growth factor axis , 2008, The Prostate.

[50]  Cheri L van Patten,et al.  Diet and dietary supplement intervention trials for the prevention of prostate cancer recurrence: a review of the randomized controlled trial evidence. , 2008, The Journal of urology.

[51]  E. Platz,et al.  Obesity and prostate cancer: making sense out of apparently conflicting data. , 2007, Epidemiologic reviews.

[52]  T. Giordano,et al.  NF-κB in breast cancer cells promotes osteolytic bone metastasis by inducing osteoclastogenesis via GM-CSF , 2007, Nature Medicine.

[53]  M. Haluzík,et al.  Adipocytokines and cancer. , 2006, Physiological research.

[54]  C. Ballantyne,et al.  Eotaxin and obesity. , 2006, The Journal of clinical endocrinology and metabolism.

[55]  A. Aljada,et al.  Increase in intranuclear nuclear factor kappaB and decrease in inhibitor kappaB in mononuclear cells after a mixed meal: evidence for a proinflammatory effect. , 2004, The American journal of clinical nutrition.

[56]  B. Aggarwal,et al.  Nuclear factor-kappaB: its role in health and disease. , 2004, Journal of molecular medicine.

[57]  N. Hacohen,et al.  Tumor necrosis factor-alpha suppresses adipocyte-specific genes and activates expression of preadipocyte genes in 3T3-L1 adipocytes: nuclear factor-kappaB activation by TNF-alpha is obligatory. , 2002, Diabetes.

[58]  K. Setchell,et al.  Production and metabolism of lignans by the human faecal flora. , 1985, The Journal of applied bacteriology.

[59]  U. G. Dailey Cancer,Facts and Figures about. , 2022, Journal of the National Medical Association.